Description
Tirzepatide – Research Grade Peptide (Dual GIP/GLP-1 Analog)
Description
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist analog designed specifically for controlled laboratory and in-vitro research. Its unique dual-pathway structure makes it highly valuable in studies focused on metabolic regulation, receptor activity, and peptide signaling. With exceptional purity and stability, Tirzepatide provides reliable performance for advanced scientific exploration.
Key Features
-
High-purity peptide (≥98% purity verified by HPLC)
-
Dual GIP/GLP-1 receptor agonist analog
-
Lyophilized for extended stability and flexible laboratory handling
-
Ideal for cellular, biochemical, and receptor-binding research
-
Produced in a GMP-compliant facility with meticulous quality control
Molecular Details
-
Class: Dual GIP/GLP-1 receptor agonist analog
-
Sequence: Tyr-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Asn-Gly-Gly-Pro-Ile-Ser-Lys-Lys-Lys-Lys-Lys-Lys
-
Form: Lyophilized powder
-
Molecular Weight: ~4813.5 g/mol
-
Solubility: Soluble in bacteriostatic water for lab preparation
-
Storage: Refrigerate at 2–8°C; for long-term storage, freeze at -20°C
Research Applications
Tirzepatide is commonly explored in studies involving:
-
Dual-pathway metabolic modeling
-
GIP and GLP-1 receptor engagement
-
In-vitro metabolic and appetite-related signaling
-
Peptide-stability research
-
Cellular energy-balance pathways
Packaging
Each vial contains precision-measured, research-grade Tirzepatide, lyophilized and sealed under sterile, nitrogen-flushed conditions to maintain stability and integrity during storage and transport.
Important Notice (FDA Compliance)
Tirzepatide is sold strictly for laboratory research purposes only.
Not for human use. Not for consumption, injection, or therapeutic application.
By purchasing this product, you agree to use it solely within controlled research environments.
Reviews
There are no reviews yet.